StockGlow

Memphasys Limited (MEM.AX)

Memphasys Limited develops, manufactures, and sells cell and protein separation devices, and related consumables for the healthcare, veterinary, and biotechnology market sectors in Australia.

0.01-0.07%Healthcare
Compare MEM.AX with
StockGlow Score
84
Bullish
BearishBullish
1 year ago+75.0%

The outlook

Memphasys Limited currently reads as bullish based on above its 50- & 200-day averages, 67% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendAbove its 50- & 200-day averages
52-week range67% of the way from its 52-week low to high
Market cap
$21.6M
52-wk high
0.01
52-wk low
0.00
50-day avg
0.01
200-day avg
0.01
Trailing P/E
—

Similar stocks

PAB.AXPatrys Limited$0.03-5.71%NOX.AXNoxopharm Limited$0.08+0.00%ADO.AXAnteoTech Limited$0.02-4.76%PYC.AXPYC Therapeutics Limited$1.70+1.49%CYP.AXCynata Therapeutics Limited$0.01+0.00%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy